Lars Erik Holmqvist

Lars Erik Holmqvist currently works at Fastihets AB Skutviken, as Chairman, H.
Lundbeck A, as Non-Independent Director, ALK-Abello A, as Non-Executive Director from 2015, Naga UK Topco Ltd., as Director, and Lundbeckfonden, as Trustee from 2015.
Mr. Holmqvist also formerly worked at Cytologix Corp., as President & Chief Executive Officer, Dako Denmark ApS, as President & Chief Executive Officer from 2009 to 2012, Biovica International AB, as Chairman, Tecan Group AG, as Non-Executive Director, BPL (Holdings) Ltd., as Director from 2016 to 2019, Life Healthcare Group Holdings Ltd., as Independent Non-Executive Director from 2022 to 2025, Vitrolife AB, as Independent Non-Executive Director from 2018 to 2026, Applera Corp., as Executive Member from 2004 to 2009, Agilent Technologies, Inc., as SVP, President-Diagnostics & Genomics Group from 2012 to 2014, Applied Biosystems, Inc., as President-International, Pharmacia Upjohn, as Vice President, Medtronic Europe SARL, as Vice President-Vascular & Cardiac Surgery from 1998 to 2004, and Applied Biosystems Ltd., as Vice President from 2004 to 2009.
Mr. Holmqvist received his undergraduate degree from Stockholm School of Economics and Masters Business Admin degree from the University of Mid Sweden.